T. Markham
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
T. Markham has a total of 4 co-authors. Here are the top co-authors by number of shared publications:
P. Collins
City of Dublin Skin and Cancer Hospital, Dublin 2, Ireland
4 shared publicationsS. Rogers
2 shared publicationsA. Watson
Nephrology, St. Vincent's University Hospital, Dublin, Ireland
1 shared publicationK. Sheahan
City of Dublin Skin and Cancer Hospital, Dublin 2, Ireland.*Department of Pathology,St Vincent’s University Hospital, Dublin 4, Ireland
1 shared publication
Latest Publications
- 18 July 2008
- Published by Oxford University Press (OUP) in British Journal of Dermatology
- Vol. 145 (3) , 502-504
Topical 5-aminolaevulinic acid photodynamic therapy for extensive scalp actinic keratoses
- 18 July 2008
- Published by Oxford University Press (OUP) in British Journal of Dermatology
- Vol. 145 (3) , 502-504
Topical 5-aminolaevulinic acid photodynamic therapy for extensive scalp actinic keratoses
- Open Access
- 1 March 2003
- Published by American Medical Association (AMA) in Archives of Dermatology
- Vol. 139 (3) , 325-328
Narrowband UV-B (TL-01) Phototherapy vs Oral 8-Methoxypsoralen Psoralen–UV-A for the Treatment of Chronic Plaque Psoriasis
ORAL 8-methoxypsoralen photochemotherapy (8-MOP psoralen–UV-A [PUVA]) is a well-established and effective treatment for psoriasis.1-5 The main concern with PUVA is the risk of nonmelanoma skin cancers6-8 and more recently the risk of melanoma.9 The action spectra of phototherapy for psoriasis10,11 led to the development by Philips (Eindhoven, the Netherlands) of a fluorescent lamp emitting narrowband UV-B between 311 and 313 nm, referred to as the TL-01 lamp. This has been shown to be more effective than broadband UV-B in the treatment of psoriasis.12-17 A review of these treatments and guidelines has been published by the British Photodermatology Group.18
- 1 March 2003
- Published by American Medical Association (AMA) in Archives of Dermatology
- Vol. 139 (3) , 325-328
Open AccessNarrowband UV-B (TL-01) Phototherapy vs Oral 8-Methoxypsoralen Psoralen–UV-A for the Treatment of Chronic Plaque Psoriasis
ORAL 8-methoxypsoralen photochemotherapy (8-MOP psoralen–UV-A [PUVA]) is a well-established and effective treatment for psoriasis.1-5 The main concern with PUVA is the risk of nonmelanoma skin cancers6-8 and more recently the risk of melanoma.9 The action spectra of phototherapy for psoriasis10,11 led to the development by Philips (Eindhoven, the Netherlands) of a fluorescent lamp emitting narrowband UV-B between 311 and 313 nm, referred to as the TL-01 lamp. This has been shown to be more effective than broadband UV-B in the treatment of psoriasis.12-17 A review of these treatments and guidelines has been published by the British Photodermatology Group.18
- 1 March 2002
- Published by Oxford University Press (OUP) in Clinical and Experimental Dermatology
- Vol. 27 (2) , 111-114
Adverse effects with long-term cyclosporin for severe psoriasis
Summary The use of cyclosporin A (CSA) for the treatment of severe psoriasis is well established. However its use is limited by its adverse effects, especially nephrotoxicity. We reviewed 28 patients...
- 1 March 2002
- Published by Oxford University Press (OUP) in Clinical and Experimental Dermatology
- Vol. 27 (2) , 111-114
Adverse effects with long-term cyclosporin for severe psoriasis
Summary The use of cyclosporin A (CSA) for the treatment of severe psoriasis is well established. However its use is limited by its adverse effects, especially nephrotoxicity. We reviewed 28 patients...
- 1 September 2001
- Published by Oxford University Press (OUP) in British Journal of Dermatology
- Vol. 145 (3) , 502-504
Topical 5-aminolaevulinic acid photodynamic therapy for extensive scalp actinic keratoses.
Scalp actinic keratoses (AKs) are common, particularly in elderly bald males. Cryotherapy and 5-fluorouracil are effective for localized AKs but are limited in extensive disease. Topical 5-aminolaevulinic acid photodynamic therapy (5-ALA PDT) is an alternative. We treated four patients with extensive scalp AKs with low light dose, low dose-rate topical 5-ALA PDT using a broad-spectrum visible light source. Three patients cleared and one showed significant improvement. Remission lasted 6 months.
- 1 September 2001
- Published by Oxford University Press (OUP) in British Journal of Dermatology
- Vol. 145 (3) , 502-504
Topical 5-aminolaevulinic acid photodynamic therapy for extensive scalp actinic keratoses.
Scalp actinic keratoses (AKs) are common, particularly in elderly bald males. Cryotherapy and 5-fluorouracil are effective for localized AKs but are limited in extensive disease. Topical 5-aminolaevulinic acid photodynamic therapy (5-ALA PDT) is an alternative. We treated four patients with extensive scalp AKs with low light dose, low dose-rate topical 5-ALA PDT using a broad-spectrum visible light source. Three patients cleared and one showed significant improvement. Remission lasted 6 months.
- 1 June 2001
- Published by Oxford University Press (OUP) in British Journal of Dermatology
- Vol. 144 (6) , 1262-1263
Topical 5-aminolaevulinic acid photodynamic therapy for tumour-stage mycosis fungoides
- 1 June 2001
- Published by Oxford University Press (OUP) in British Journal of Dermatology
- Vol. 144 (6) , 1262-1263
Topical 5-aminolaevulinic acid photodynamic therapy for tumour-stage mycosis fungoides